Earnings Analysis Dashboard – NATHBIOGEN
Structured AI analysis of company financial results designed to help traders and investors quickly understand key performance trends.
Type of Announcement
The Board of Directors of Nath Bio-Genes (India) Limited announced the consolidated financial results for the quarter and year ended 31st March 2026, along with other corporate decisions. These include declarations regarding financial performance, dividend announcements, and reappointment of directors.
Revenue
₹515.93 Crs.
▲+25.95% QoQ
Net Profit
₹-0.09 Crs.
▼ -100.60% YoY
EPS
₹-0.79
▼ -288.10% QoQ
EBITDA Margin
12.22%
▼ Declining
Key Financial Numbers (Quarter)
| Metric |
Current Quarter (Mar 2026) |
Previous Quarter (Dec 2025) |
Same Quarter Last Year (Mar 2025) |
| Revenue (₹ Crs.) |
₹515.93 |
₹658.59 |
₹518.68 |
| Net Profit (₹ Crs.) |
₹-0.09 |
₹160.49 |
₹148.10 |
| EPS |
₹-0.79 |
₹0.89 |
₹0.42 |
| EBITDA Margin (%) |
12.22% |
15.69% |
18.48% |
What EPS Means
EPS (Earnings Per Share) shows how much profit a company generates for each share.
Higher EPS usually indicates stronger profitability and better earnings power for shareholders.
What EBITDA Margin Means
EBITDA Margin measures operating profitability before interest, tax, depreciation and amortization.
A higher margin suggests the company is generating stronger operating profits from its revenue.
Revenue Trend
Mar 2026
₹515.93 Crs.
Dec 2025
₹658.59 Crs.
Mar 2025
₹518.68 Crs.
Profit Trend
Mar 2026
₹-0.09 Crs.
Dec 2025
₹160.49 Crs.
Mar 2025
₹148.10 Crs.
Quick Interpretation
- QoQ revenue trend: Decline (-21.69%)
- YoY profit trend: Sharp drop (-100.06%)
- EBITDA Margin trend: Declining
Major Corporate Events
- Proposed dividend of ₹2 per share for the financial year 2025-26.
- Reappointment of Mr. Hitesh Rajnikant Purohit as an Independent Director effective 30th March 2027.
- Appointment of M/s K.P. Sahasrabudhe & Co. as Internal Auditors for FY 2026-27.
Trading Signals
- Positive Factors: Strong operational cash flows. Dividend declaration.
- Negative Factors: Declining revenue and profit. Falling EBITDA margin.
Overall Sentiment
Bearish
Disclaimer
This report has been analysed and generated using AI based on publicly available corporate announcements and financial disclosures published by the company on NSE INDIA Website.
We are not registered with SEBI as an investment advisor or research analyst. This report is provided strictly for informational and educational purposes only.
Investors should not treat this analysis as financial advice, stock recommendation, or investment guidance. Always conduct your own research or consult a SEBI-registered financial advisor before making investment decisions.
The platform does not guarantee accuracy, completeness, or timeliness of the extracted information.